Brooklyn ImmunoTherapeutics (BTX) Competitors $0.25 +0.00 (+1.05%) (As of 12/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrends BTX vs. ALFIW, and NLOKShould you be buying Brooklyn ImmunoTherapeutics stock or one of its competitors? The main competitors of Brooklyn ImmunoTherapeutics include Alfi (ALFIW), and NortonLifeLock (NLOK). These companies are all part of the "information" sector. Brooklyn ImmunoTherapeutics vs. Alfi NortonLifeLock Brooklyn ImmunoTherapeutics (NYSE:BTX) and Alfi (NASDAQ:ALFIW) are both information companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, community ranking, dividends, institutional ownership, valuation, analyst recommendations, media sentiment, profitability and earnings. Do insiders and institutionals hold more shares of BTX or ALFIW? 26.0% of Brooklyn ImmunoTherapeutics shares are owned by institutional investors. 20.5% of Brooklyn ImmunoTherapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Is BTX or ALFIW more profitable? Company Net Margins Return on Equity Return on Assets Brooklyn ImmunoTherapeuticsN/A N/A N/A Alfi N/A N/A N/A Which has preferable valuation & earnings, BTX or ALFIW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBrooklyn ImmunoTherapeuticsN/AN/AN/A-$2.27-0.11Alfi$200.68KN/AN/AN/AN/A Does the MarketBeat Community favor BTX or ALFIW? Brooklyn ImmunoTherapeutics and Alfi both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformBrooklyn ImmunoTherapeuticsOutperform VotesNo VotesUnderperform Votes99100.00% AlfiN/AN/A Does the media prefer BTX or ALFIW? In the previous week, Brooklyn ImmunoTherapeutics had 1 more articles in the media than Alfi. MarketBeat recorded 1 mentions for Brooklyn ImmunoTherapeutics and 0 mentions for Alfi. Brooklyn ImmunoTherapeutics' average media sentiment score of 0.00 equaled Alfi'saverage media sentiment score. Company Overall Sentiment Brooklyn ImmunoTherapeutics Neutral Alfi Neutral SummaryBrooklyn ImmunoTherapeutics beats Alfi on 3 of the 4 factors compared between the two stocks. Ad DTICackling Kamala hates this companyDo you want to see one of the most exciting election trades of all time? A trade that could help America become 100% energy independent… Reduce energy costs to virtually zero… And hand investors what could be a stunning return in just a few years’ time? It all has to do with a little known company that is helping to kick off the next great American energy revolution. Before that happens, you need to see the details here. Get Brooklyn ImmunoTherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip Chart BTX vs. The Competition Export to ExcelMetricBrooklyn ImmunoTherapeuticsTelevision Broadcasting IndustryInformation SectorNYSE ExchangeMarket Cap$14.71M$14.71M$5.33B$19.19BDividend YieldN/AN/A3.69%3.61%P/E Ratio-0.11N/A7.1241.30Price / SalesN/AN/A5.6417.58Price / CashN/AN/AN/A21.28Price / BookN/AN/AN/A5.32Net IncomeN/AN/AN/A$989.88M7 Day Performance-13.46%-13.46%-2.97%-3.54%1 Month Performance-59.31%-59.31%-11.34%-3.68%1 Year Performance-85.02%-85.02%-9.95%12.14% Brooklyn ImmunoTherapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BTXBrooklyn ImmunoTherapeuticsN/A$0.25+1.1%N/A-83.7%$14.71MN/A-0.11N/AALFIWAlfiN/A$0.04-21.0%N/AN/A$0.00$200,684.000.0040Gap DownHigh Trading VolumeNLOKNortonLifeLock0.7545 of 5 stars$29.86-0.5%N/A+17.9%$17.06B$2.82B20.88N/A Related Companies and Tools Related Companies ALFIW Competitors NLOK Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:BTX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Brooklyn ImmunoTherapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Brooklyn ImmunoTherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
